A former market access head at a specialty pharmaceutical company details PBM rebate mechanics, gross-to-net erosion, and what exclusion threats really cost.
HEALTHCARE Transcripts
Anonymised expert call transcripts across HEALTHCARE & LIFE SCIENCES. Free previews; full transcripts for subscribers.
- Industry
- HEALTHCARE & LIFE SCIENCES
- Transcripts
- 3
- Full access
- Subscription
HEALTHCARE & LIFE SCIENCES Transcripts
3 availableRecently-departed commercial director at a top-10 pharma discusses the launch dynamics for biologic products in the post-IRA US market.
Recently-retired interventional cardiologist discusses the practical adoption dynamics of robotic cardiac procedures through 2025 and into 2026.
Frequently Asked
2 questions- Q.01
- Q.02
What do these HEALTHCARE & LIFE SCIENCES expert transcripts cover?
3 anonymised expert interviews on HEALTHCARE & LIFE SCIENCES. Contributors include Former head of market access at a specialty pharmaceutical company; Recently-departed Commercial Director at a top-10 pharmaceutical company, oncology biologics; Recently-retired interventional cardiologist at a major US academic medical centre. Every transcript has a free preview; full transcripts are available on subscription.
Are the experts behind these HEALTHCARE & LIFE SCIENCES transcripts vetted and compliant?
Yes. Each interview is with a vetted former operator, fully anonymised, and MNPI-screened under FieldSignal's compliance framework.